ORIENTBIO Inc. (002630) — Cash Flow Quality Index
Latest as of March 2024:
0.12x
ORIENTBIO Inc. (002630) has a Cash Flow Quality Index of 0.12x as of March 2024. Operating cash flow of ₩1.35 Billion is below net income of ₩10.99 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ORIENTBIO Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.12x
Operating CF / Net Income
Operating Cash Flow
₩1.35 Billion
KRW
Net Income
₩10.99 Billion
KRW
Data as of
Mar 2024
Most recent filing
ORIENTBIO Inc. Cash Flow Quality Index (2007–2024)
Historical Cash Flow Quality Index for ORIENTBIO Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 002630 cash generation efficiency.
Annual Cash Flow Quality Index for ORIENTBIO Inc. (2007–2024)
Year-by-year earnings quality comparison for ORIENTBIO Inc..
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩3.76 Billion | ₩12.87 Billion | ▲ +324.5% |
| 2022 | 0.07x | ₩2.35 Billion | ₩34.20 Billion | ▼ -98.8% |
| 2013 | 5.80x | ₩5.09 Billion | ₩878.82 Million | ▲ +656.8% |
| 2011 | 0.77x | ₩3.11 Billion | ₩4.07 Billion | ▼ -73.4% |
| 2007 | 2.88x | ₩1.52 Billion | ₩526.73 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.